Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one analysts that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and thirteen have given a buy recommendation to the company. […]

Leave a Reply

Your email address will not be published.

Previous post Oil extends gains on supply concerns
Next post BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Average PT from Analysts